Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Sep 28, 2020 5:28pm
803 Views
Post# 31632811

Anonymous seems desperate to create some selling volume

Anonymous seems desperate to create some selling volumeShort selling is not easy or cheap: if you get stuck short and company announce good progress or big updates then it can cost you lot of money. We all know we are getting those updates by October 15, 2020. So, I think anyone is short need to cover their short selling quickly. Whoever is behind this Anonymous group, know very well and seems desperate to create some volume. Why else someone be selling at these prices when you know everything going to change when these testing centres are launched. Even half of projected revenue can take QuestCap share price over $3-$4.
 
Once these Covid-19 testing centres are launched and company go out public and wider investor community with projected revenue numbers backed up by testing centres in every State. It will be extremely hard to miniplate QSC share prices to keep it anywhere close to .20-.30 cents. QuestCap should already be out creating awareness about QSC and projected revenue but I understand QuestCap management wants to play it safe. They want to wait until all these Collection Sites are launched.
 
We all here at QuestCap know very well QSC is about to launch 165 covid-19 testing centres in about 2 weeks. Those testing centres can generate up to 165x$270,000= $44 million revenue recurring every month. If we go with 40% profit margin, that is about $17.8 million profit per month and $213 million per year. We can time this to anywhere from 5 to 20 times for QSC market cap. So QuestCap market cap with even 5x should be over billion. Which make QSC share price around $7 per share.
 
These above calculations are only part of the story. QuestCap also, have 28% owned portfolio company providing Covid-19 testing as wholesale and also in their own lab as retail https://www.facebook.com/ipssanaty . So Sanaty a Columbian company can easily expand to many other south American countries to sell PCL covid-19 tastings.
 
QuestCap also funding Sinai Health Foundation to support the development of a diagnostic test for COVID-19 and study trial already started https://www.lunenfeld.ca/shawl/files/file/SHAWL-1%20Information%20Slides_2020Aug25(1).pdf
 
QuestCap also funding Sunnybrook Research Institute ($1 million).  Sunnybrook Translational Research Group for Emerging and Respiratory Viruses is focused on vaccines and therapeutics. Dr. Samira Mubareka is also Therapeutics Task Force science advisors to the Canadian GOVT https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01780.html
 
Once you have those covid-19 testing centres running, they can add as many addon services or different kind of tests to genrate even more revenue.
 
So, I think any long needs to hold for another 2-4 weeks before we see prices go up and we get rewarded with profit. Any Short need to cover it quickly before QSC shoot above $3-$4 and you start getting margin calls. If not keep selling at these prices, some of us will buy some more.
 
Anonymous sold and brought most of the volume today.  

House Positions for C:QSC from 20200928 to 20200928
House Bought $Val Ave Sold $Val Ave Net $Net
79 CIBC 60,270 11,121 0.185 5,000 862 0.172 55,270 -10,259
33 Canaccord 36,310 6,723 0.185 6,380 1,180 0.185 29,930 -5,543
2 RBC 42,000 7,850 0.187 20,424 3,770 0.185 21,576 -4,080
7 TD Sec 21,000 3,890 0.185 5,500 1,045 0.19 15,500 -2,845
14 ITG 11,000 2,050 0.186 500 92 0.184 10,500 -1,958
9 BMO Nesbitt 13,274 2,522 0.19 5,000 950 0.19 8,274 -1,572
19 Desjardins 2,050 369 0.18 0   2,050 -369
36 Latimer 380 70 0.184 1,134 215 0.19 -754 145
85 Scotia 0   5,000 975 0.195 -5,000 975
8 Eight 0   20,500 3,895 0.19 -20,500 3,895
1 Anonymous 137,654 25,116 0.182 254,500 46,727 0.184 -116,846 21,611
TOTAL 323,938 59,711 0.184 323,938 59,711 0.184 0 0

<< Previous
Bullboard Posts
Next >>